Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominica Willmann

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Chembiochem : a European Journal of Chemical Biology|April 1, 2020
Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia CellsEva-Maria Herrlinger, Mirjam Hau, Desiree Melanie Redhaber, et al.
Journal of Biomolecular Screening|April 2, 2014
Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide SubstrateMartin L Schmitt, Kathrin I Ladwein, Luca Carlino, et al.
Journal of Medicinal Chemistry|September 7, 2013
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activityMartin L Schmitt, Alexander-Thomas Hauser, Luca Carlino, et al.
International Journal of Cancer|March 27, 2012
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitorDominica Willmann, Soyoung Lim, Stefan Wetzel, et al.
Cell Death & Disease|February 24, 2017
Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4Josefina Castex, Dominica Willmann, Toufike Kanouni, et al.
Oncotarget|December 16, 2014
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsCordula A Jilg, Anett Ketscher, Eric Metzger, et al.
Archiv Der Pharmazie|July 15, 2024
Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylasesJohannes Seitz, Marina Auth, Tony Prinz, et al.
Cancer Research|November 5, 2021
KMT9 Controls Stemness and Growth of Colorectal CancerChristopher Berlin, Félicie Cottard, Dominica Willmann, et al.
European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.
Cell Reports|October 21, 2016
Lsd1 Ablation Triggers Metabolic Reprogramming of Brown Adipose TissueDelphine Duteil, Milica Tosic, Franziska Lausecker, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Chembiochem : a European Journal of Chemical Biology|April 1, 2020
Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia CellsEva-Maria Herrlinger, Mirjam Hau, Desiree Melanie Redhaber, et al.
Journal of Biomolecular Screening|April 2, 2014
Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide SubstrateMartin L Schmitt, Kathrin I Ladwein, Luca Carlino, et al.
Journal of Medicinal Chemistry|September 7, 2013
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activityMartin L Schmitt, Alexander-Thomas Hauser, Luca Carlino, et al.
International Journal of Cancer|March 27, 2012
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitorDominica Willmann, Soyoung Lim, Stefan Wetzel, et al.
Cell Death & Disease|February 24, 2017
Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4Josefina Castex, Dominica Willmann, Toufike Kanouni, et al.
Oncotarget|December 16, 2014
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsCordula A Jilg, Anett Ketscher, Eric Metzger, et al.
Archiv Der Pharmazie|July 15, 2024
Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylasesJohannes Seitz, Marina Auth, Tony Prinz, et al.
Cancer Research|November 5, 2021
KMT9 Controls Stemness and Growth of Colorectal CancerChristopher Berlin, Félicie Cottard, Dominica Willmann, et al.
European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.
Cell Reports|October 21, 2016
Lsd1 Ablation Triggers Metabolic Reprogramming of Brown Adipose TissueDelphine Duteil, Milica Tosic, Franziska Lausecker, et al.
Pageof 3